OsstellConnect and Beacon

Back to Press

OsstellConnect reaches 500,000 ISQ measurements – A milestone in dental implant stability tracking

Osstell announces a major milestone as its digital platform, OsstellConnect, surpasses 500,000 registered ISQ measurements. It has become the first global solution for clinicians to collect, analyze, and benchmark implant stability data, supporting more than 185,000 patients worldwide.

Gothenburg, Sweden – 21st of August, 2025: We are proud to announce a major milestone: more than 500,000 ISQ values have now been registered in OsstellConnect, our digital platform that helps clinicians worldwide optimize implant treatments.

 

The first global platform for implant stability tracking

OsstellConnect is the first global solution enabling clinicians to collect, analyze, and benchmark ISQ (Implant Stability Quotient) measurements in daily practice. Since its launch in 2017, OsstellConnect has continued to evolve with new features such as mobile app, study group, and consultation tool. Today, the platform supports more than 185,000 patients and 336,000 implants, with over 500,000 ISQ values recorded.

 

“A testament to clinicians’ trust” – Malin Gustavsson, CEO

“Reaching half a million ISQ values in OsstellConnect is a testament to the trust clinicians place in our technology,” said Malin Gustavsson, CEO at Osstell. “Each ISQ measurement represents a patient case where objective data supported treatment decisions, and we are proud to help clinicians around the world ensure safer, more predictable implant outcomes.”

 

The future of OsstellConnect

Looking ahead, OsstellConnect will continue to grow and develop, offering clinicians even more ways to support their treatment decisions and enhance patient outcomes in the years ahead.

 

Download the Press Release here

 

 

Enquiries and contact

Hanne Nyberg
Digital Marketing Manager
Tel.: +46 76 697 85 29
E-Mail: hanne.nyberg@osstell.com
Osstell AB
Stampgatan 14
411 01 Gothenburg
Sweden

 

About Osstell

Osstell is the global leader in implant stability measurement and osseointegration progress monitoring. Since the company was founded in 1999, over thousands of scientific studies have been published confirming the clinical value of Osstell’s proprietary Resonance Frequency Analysis (RFA) technology and the Osstell ISQ scale (Implant Stability Quotient).

2018 Osstell became a part of the W&H Group, a global leader in the development and manufacture of medical technology products with over 1300 employees. Osstell is headquartered in Gothenburg, Sweden, the birthplace of dental implants. Our product solution is available in more than 70 countries, through our own presence and a vast network of distributors for the rest of the world. We empower dental professionals by providing objective implant stability measurements to provide each patient with optimal time to teeth, and improve patient confidence.